Abstract:Background We have previously reported that C-peptide exerts preventive and therapeutic effects on diabetic neuropathy in type 1 diabetic BB/Wor-rats and that it prevents duration-dependent hippocampal apoptosis in the same animal model. In the present study, we examined human neuroblastoma SH-SY5Y cells to examine whether C-peptide stimulates cell proliferation/neurite outgrowth and whether it has antiapoptotic effects.Methods For neurite outgrowth, C-peptide and/or insulin or IGF-1. Neurites were visualized with NF-L antibody and measured morphometrically. Cell numbers were determined using an electronic cell counter. Scrambled C-peptide was used as a negative SH-SY5Y cells were incubated with control. For assessment of apoptosis, 100 mM glucose for 24 h, and the effects of C-peptide and/or insulin or IGF-1 were examined. Apoptosis was demonstrated by transferase-mediated dUTP nick-end labeling (TUNEL)/4,6-diamidino-2-phenylindole (DAPI) stainings, flow cytometry and changes in the expression of Bcl(2). Activation of insulin signaling intermediaries was determined by Western blots. Translocation of NF-kappaB was demonstrated immunocytochemically.Results C-peptide but not scrambled C-peptide stimulated cell proliferation and neurite outgrowth. in the presence of 4 nM insulin, 3 nM C-peptide significantly increased autophosphorylation of the insulin receptor (IR) but not that of the insulin-like growth factor 1 receptor (IGF-1R). It stimulated phosphoinositide 3-kinase (PI-3 kinase) and p38 mitogen-activated protein (MAP) kinase activation, enhanced the expression and translocation of nuclear factor-kappaB (NF-kappaB), promoted the expression of Bcl(2) and reduced c-jun N-terminal kinase (JNK) phosphorylation in excess of that of insulin alone.Conclusions C-peptide in the presence of insulin exerts synergistic effects on cell proliferation, neurite outgrowth and has in the presence of insulin an antiapoptotic effect on high glucose-induced apoptosis but less so on hyperosmolar-induced apoptosis. These effects are likely to be mediated via interactions with the insulin signaling pathway. Copyright (C) 2003 John Wiley Sons, Ltd.

Sequential Abnormalities in Type 1 Diabetic Encephalopathy and the Effects of C-Peptide.

The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.

Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide

C-Peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes

C-peptide and diabetic encephalopathy

Type 1 Diabetic Neuropathy and C-peptide

The Beneficial Effects of C-Peptide on Diabetic Polyneuropathy.

C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats.

Proinsulin C-peptide Replacement in Type 1 Diabetic BB/Wor-rats Prevents Deficits in Nerve Fiber Regeneration.

C-Peptide Improves Neuropathy in Type 1 Diabetic Bb/Wor-Rats

C-Peptide Reverses Nociceptive Neuropathy in Type 1 Diabetes

Physiological effects and therapeutic potential of proinsulin C-peptide

Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical Trial

Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes-Time for Translational Studies or Back to the Basics?

The Disturbance of Hippocampal Camkii/Pka/Pkc Phosphorylation in Early Experimental Diabetes Mellitus

The Role of Impaired Insulin/igf Action in Primary Diabetic Encephalopathy

Hippocampal neuronal apoptosis in type 1 diabetes.

Insulin and IGF-1 receptors, nitrotyrosin and cerebral neuronal deficits in two young patients with diabetic ketoacidosis and fatal brain edema

Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications

C‐peptide in diabetes: A player in a dual hormone disorder?

C-peptide Enhances Insulin-Mediated Cell Growth and Protection Against High Glucose-Induced Apoptosis in SH-SY5Y Cells.